CID 3011999

5-(1-adamantyl)-3-[[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methyl]-1,3,4-oxadiazole-2-thione

Structural Information

Molecular Formula
C25H31F3N4OS
SMILES
C1CN(CCN1CC2=CC=CC=C2C(F)(F)F)CN3C(=S)OC(=N3)C45CC6CC(C4)CC(C6)C5
InChI
InChI=1S/C25H31F3N4OS/c26-25(27,28)21-4-2-1-3-20(21)15-30-5-7-31(8-6-30)16-32-23(34)33-22(29-32)24-12-17-9-18(13-24)11-19(10-17)14-24/h1-4,17-19H,5-16H2
InChIKey
XONFESLXVYCECB-UHFFFAOYSA-N
Compound name
5-(1-adamantyl)-3-[[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methyl]-1,3,4-oxadiazole-2-thione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

492.21707 Da
Monoisotopic Mass

5.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 493.22435 207.5
[M+Na]+ 515.20629 209.6
[M-H]- 491.20979 202.2
[M+NH4]+ 510.25089 217.0
[M+K]+ 531.18023 204.0
[M+H-H2O]+ 475.21433 193.3
[M+HCOO]- 537.21527 197.5
[M+CH3COO]- 551.23092 209.5
[M+Na-2H]- 513.19174 208.7
[M]+ 492.21652 204.9
[M]- 492.21762 204.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.